Company / SG&A per Share
NewAmsterdam Pharma Co N.V. SG&A per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.90
FY2025
5-year range
$0.46 / $1.03
FY2021-FY2025
Trend
+20.3%
vs FY2024
Sector context
#127 of 206
Health Care
What the data says
At $0.90, NewAmsterdam Pharma Co N.V.'s sg&a per share ranks #80 of 206 in the Health Care sector. Increased from $0.46 to $0.90 over the past 2 years.
Based on SEC 10-K filings.
0.90 in FY2025 with a 3-year CAGR of -4.4%.
Increased from $0.46 to $0.90 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -4.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#80 of 206 in Health CareTop 38% of 206This company $0.90 Sector average $44.68
▼
-98.0% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 20.3% year-over-year.
- Ranks #127 out of 206 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2022.
- Lowest sg&a per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.90 | +20.3% |
| FY2024 | $0.75 | +63.0% |
| FY2023 | $0.46 | -55.5% |
| FY2022 | $1.03 | +88.1% |
| FY2021 | $0.55 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026